# Dose-escalation, Repeated and Single Oral Dosing Study

> **NCT02419820** · PHASE1 · TERMINATED · sponsor: **IlDong Pharmaceutical Co Ltd** · enrollment: 104 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** APD791
- **DRUG:** Clopidogrel
- **DRUG:** Aspirin
- **DRUG:** Placebo for APD791

## Key facts

- **NCT ID:** NCT02419820
- **Lead sponsor:** IlDong Pharmaceutical Co Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-03
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 104 (ACTUAL)
- **Why stopped:** Sponsor Decision
- **Last updated:** 2019-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02419820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02419820, "Dose-escalation, Repeated and Single Oral Dosing Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02419820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*